Table 1 Demographic and clinical characteristics of MDD patients and healthy controls at baseline
From: RPS6KA5 methylation predict response to 6-week treatment for adolescent MDD patients
Characteristic | MDD patients (n = 87) | Controls (n = 53) | F or χ2 | p |
|---|---|---|---|---|
Demographic characteristics | ||||
  Age (years) | 14.47 ± 1.47 | 14.21 ± 1.36 | 0.181 | 0.292 |
  Sex (Male/Female) | 15/72 | 14/39 | 1.688 | 0.194 |
  Level of education (Junior/Senior) | 50/37 | 39/14 | 3.693 | 0.055 |
Clinical characteristics | ||||
  CCSQ total score | 137.78 ± 39.56 | 83.02 ± 22.97 | 18.984 |  < 0.001 |
  Peer bullying | 28.60 ± 12.25 | 19.51 ± 6.41 | 30.112 |  < 0.001 |
  Childhood abuse and neglect | 64.07 ± 21.99 | 40.26 ± 14.42 | 11.182 |  < 0.001 |
  Adverse childhood experiences | 45.11 ± 13.23 | 23.25 ± 6.95 | 23.194 |  < 0.001 |
  BDI score | 34.24 ± 8.78 | 7.13 ± 6.61 | 1.425 |  < 0.001 |